Optimizing Imaging in ER-positive Metastatic Breast Cancer to Improve Clinical Outcomes

home / news-network / optimizing-imaging-in-er-positive-metastatic-breast-cancer-to-improve-clinical-outcomes

Gary Ulaner, MD, PhD and Jeremy Force, DO discuss the role of various strategies to detect estrogen receptor (ER)-positive breast cancer, with particular focus on the role of 18F-FES-PET imaging in diagnosis and treatment of ER-positive breast cancer and in improving patient outcomes.